Asia Accelerates Myeloma Research

myelomaMinBannerTemplate4.26.png

| INSPIRATION | Latest Research

540x270DurieAsia.png

Second Asian Myeloma Network Summit in Beijing, China Is a Big Success

Myeloma experts from seven countries met in Beijing this past weekend to share the latest in treatment approaches and disease research at the second annual Asian Myeloma Network Summit. Convened by the IMF, the Summit’s hot topics ranged from CAR T-cell therapy to genomics to minimal residual disease. IMF Chairman Brian G.M. Durie, MD, explains it all.

LearnMoreButton.png

| INSPIRATION | Laughter

540x270JefferiesBanner.png

Laugh with Jim Jefferies, Sasheer Zamata, and More at the IMF’s 12th Annual Comedy Celebration on November 3

The IMF 12th Annual Comedy Celebration takes place on Saturday, November 3, at 8 p.m. at The Wilshire Ebell Theatre in Los Angeles. This year’s event is hosted by Kevin Nealon and features all-star performers. This week, we spotlight Jim Jefferies and Sasheer Zamata. You can catch Jim Jefferies starring in his third Netflix comedy special, Jim Jefferies: This Is Me Now. Additionally, March 2018 marked the premiere of season 2 of Jim’s eponymous Comedy Central series, The Jim Jefferies Show. As a strong voice in late night, the weekly series features Jim traveling across the globe to tackle the top news stories and controversial issues of the day.

Also on the bill for this event is Sasheer Zamata, who was a cast member on Saturday Night Live for four seasons and has appeared on This American Life, Transparent, People of Earth, At Home with Amy Sedaris and Inside Amy Schumer. She’s in the films I Feel Pretty, The Outdoorsman, Yoga Hosers, Sleight, and Deidra & Laney Rob a Train, and has done voice over for Bojack Horseman, Call of Duty, Lucas Bros. Moving Co., and Albert (Nickelodeon).

Reserve Tickets Button.png

| INSPIRATION | Easy Ways to Give

250x250AmazonSmile.png

| EDUCATION | Living Well with Myeloma

ClinicalTrials250x250.png

Purchase with a Purpose

Clinical Trials in Myeloma

With Halloween around the corner, it's a great time to shop at smile.amazon.com. Choose the International Myeloma Foundation as the organization you are supporting as part of Amazon Smile. Then, for any of your purchases made on their site, Amazon will donate to the IMF at no added cost to you. It’s a win-win!

Join Dr. Joseph Mikhael, IMF’s Chief Medical Officer, as he moderates this teleconference on clinical trials and their importance. Dr. Mikhael will discuss:

  • the types of trials (phase I, phase II, phase III)
  • how to interpret results of trials
  • the process of informed consent
  • reasons why patients may want to enroll

He will also preview some leading trials in multiple myeloma.

ShopNowButton.png

Register Now Button.png

| ACTION | Bid for a Cure

540x270AuctionArea.png

Auction Live and Open for Bidding

The IMF silent auction catalog is now online and ready for pre-bidding! Some of the exciting items in our auction this year include:

  • Sports and Hollywood memorabilia
  • Exciting trips, flights, and hotel stays
  • High-end makeup, skincare, and beauty products
  • Beautiful artwork, photography, and jewelry from notable artists
  • Restaurant gift cards, tickets to Broadway shows, TV set visits, and more!

Pre-bidding will only be available until next Friday. To improve your chances of grabbing the auction item of your choice, purchase a ticket to the night's event. If you cannot be at the 12th Annual IMF Comedy Celebration, we can assign a volunteer to bid on your behalf up to your maximum amount. Just contact auction@myeloma.org for information!

All auction proceeds fund the Peter Boyle Research Fund of the IMF and benefits efforts to find a cure for multiple myeloma.

BidNowButton.png

| INNOVATION | FDA Review

490x245Pills.png

FDA Allows Priority Review and Accepts a New Drug Application for Selinexor

The Food and Drug Administration has accepted Karyopharm’s “filing with Priority Review” for a “New Drug Application (NDA) seeking accelerated approval of selinexor.” Selinexor is a first-in-class, oral SINE compound that is being considered for the treatment of patients with penta-refractory multiple myeloma. Learn more about selinexor with this Ask Dr. Durie video, or follow the link below for the latest FDA news.

LearnMoreButton.png

| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series

DurieVideoBox10.25.png

CLINICAL TRIALS

EVENTS

BOSTON Trial Fact Sheet

New isatuximab Clinical Trial: the IMROZ Study

New isatuximab Clinical Trial: the IKEMA Study

New ixazomib Clinical Trials: Learn How to Participate

Join the conversation about myeloma on the Smart Patients Message Board

Ongoing
Nancy's Passion for Patients
Nationwide

October 28, 2018
Red House Carnival
Somerville, MA

November 3, 2018
12th Annual Comedy Celebration
Los Angeles, CA

Ongoing Fundraiser
Moseman’s 50th Anniversary
Nationwide

March 15-16, 2019
IMF Patient & Family Seminar
Boca Raton, FL

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Celgene Corporation, Genentech, and Takeda Oncology
and individuals like you who supported the IMF this year